Tumor-suppressing viruses, genes, and drugs : innovative cancer therapy approaches / edited by Hiroshi Maruta.
Material type:
TextPublication details: San Diego : Academic Press, ©2002.Description: 1 online resource (xv, 425 pages) : illustrationsContent type: - text
- computer
- online resource
- 9780080549026
- 0080549020
- 1281119237
- 9781281119230
- 9786611119232
- 661111923X
- Antioncogenes
- Cancer -- Gene therapy
- Viruses -- Therapeutic use
- Cancer -- Treatment -- Technological innovations
- Cancer -- Molecular aspects
- Gene therapy
- Neoplasms -- therapy
- Antineoplastic Agents -- therapeutic use
- Genetic Therapy
- Genes, Tumor Suppressor
- Neoplasms -- genetics
- Neoplasms -- virology
- Antioncogènes
- Cancer -- Thérapie génique
- Virus -- Emploi en thérapeutique
- Cancer -- Traitement -- Innovations
- Cancer -- Aspect moléculaire
- Thérapie génique
- MEDICAL -- Oncology
- HEALTH & FITNESS -- Diseases -- Cancer
- Antioncogenes
- Cancer -- Gene therapy
- Cancer -- Molecular aspects
- Cancer -- Treatment -- Technological innovations
- Viruses -- Therapeutic use
- Tumeurs -- thérapie
- Gentherapie
- Tumorhemmung
- Krebs Medizin
- Pharmakotherapie
- Cancer -- Chimiothérapie
- Cancer -- Thérapie génique
- Virus -- Emploi en thérapeutique
- 616.99/406 21
- RC268.43 .T855 2002
- 2002 A-356
- QZ 266
- digitized 2010 HathiTrust Digital Library committed to preserve
| Item type | Home library | Collection | Call number | Materials specified | Status | Date due | Barcode | |
|---|---|---|---|---|---|---|---|---|
Electronic-Books
|
OPJGU Sonepat- Campus | E-Books EBSCO | Available |
Includes bibliographical references and index.
Ch. 1. Oncolytic viruses: virotherapy for cancer -- Ch. 2. Reovirus therapy of Ras-associated cancers -- Ch. 3. Oncolytic herpes simplex virus (G207) therapy: from basic to clinical -- Ch. 4. p53 and its targets -- Ch. 5. Prospects for tumor suppressor gene therapy: RB as an example -- Ch. 6. CDK inhibitors: genes and drugs -- Ch. 7. CDK inhibitors: small molecular weight compounds -- Ch. 8. NF1 and other RAS-binding peptides -- Ch. 9. Cytoskeletal tumor suppressor genes -- Ch. 10. TGF-[beta] signaling and carcinogenesis -- Ch. 11. DAN gene -- Ch. 12. Design of hammerhead ribozymes and allosterically controllable maxizymes for cancer gene therapy -- Ch. 13. Inhibitors of angiogenesis -- Ch. 14. Geranylgeranylated RhoB mediates the apoptotic and antineoplastic effects of farnesyltransferase inhibitors: new insights into cancer cell suicide -- Ch. 15. RAS binding compounds -- Ch. 16. Actin-binding drugs: MKT-007 and chaetoglobosin K (CK) -- Ch. 17. Tyr kinase inhibitors as potential anticancer agents: EGF receptor and ABL kinases -- Ch. 18. Antagonists of Rho family GTPases: blocking PAKs, ACKs, and rock -- Ch. 19. Integrin antagonists as cancer therapeutics -- Ch. 20. Functional rescue of mutant p53 as a strategy to combat cancer.
Print version record.
Use copy Restrictions unspecified star MiAaHDL
Electronic reproduction. [S.l.] : HathiTrust Digital Library, 2010. MiAaHDL
Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. MiAaHDL
http://purl.oclc.org/DLF/benchrepro0212
digitized 2010 HathiTrust Digital Library committed to preserve pda MiAaHDL
Tumor Suppressing Viruses, Genes, and Drugs profiles the new generation of cancer treatments now in development. The book examines the innovative new approaches of viral, gene, and signal therapies that promise to replace or enhance conventional methods such as surgery, radiation, and chemotherapy. The timely information presented by this book should be of interest to anyone concerned with advancing cancer treatment beyond current medical practices.
English.
eBooks on EBSCOhost EBSCO eBook Subscription Academic Collection - Worldwide
There are no comments on this title.